Miami, Florida (PRWEB) October 24, 2016 -- Last week, President Barack Obama took executive action to expand the opportunities for scientific collaboration and medical research between companies and individuals from the United States and Cuba. These changes in policy were part of a broader series of moves designed to increase the means for Americans and Cubans to work together in business, education, travel and medicine.
At the very same time the president was taking this action, an American company was taking the first steps to initiate this sort of scientific collaboration with the Cuban medical community. Regenestem (http://www.regenestem.com), a medical practice company focused on adult stem cell treatments and physician training, hosted an innovative conference in Cuba devoted to regenerative medicine.
The First Inter American Regenerative and Cellular Medicine Conference was held October 13-15, in Havana. The event was attended by 180 physicians and other medical professionals from 14 different countries.
The three-day event, organized by Regenestem Founder & CEO Ricardo De Cubas, was designed to explore stem cell therapies as a standard form of medical treatment. In addition, the conference addressed specific issues involving the process of replacing, engineering or regenerating human cells, tissues and organs to restore or establish a body’s normal function.
The roster of prominent physicians in the field of regenerative medicine who spoke at the conference were:
• Anthony Atala, M.D. - Wake Forest University, Winston-Salem, N.C.
• Rocky S. Tuan, PhD – University of Pittsburgh
• Arnold I. Caplan, PhD - Case Western Reserve University, Cleveland, Ohio
• Robert M. Nerem, PhD – Georgia Institute of Technology, Atlanta
• Jakub Tolar, M.D., PhD - University of Minnesota, Minneapolis
• Joshua M. Hare, M.D. - University of Miami Miller School of Medicine
• Charles F. Mahl, M.D. – GenLife Regenerative Medicine, Coral Gables, Fla.
“The stem cell conference organized by Ricardo De Cubas was a fine example of how international research starts with human interactions,” said Dr. Tolar, director of the Stem Cell Institute at the University of Minnesota. “Derived in part from shared knowledge of regenerative medicine literature and in part from the shared goal of alleviating human suffering anywhere in the world, the meeting of Cuban and American clinician-researchers offered a blueprint for future interactions.”
The second annual conference is scheduled for November 2017 in Varadero, Cuba.
About Regenestem, LLC
Regenestem (http://www.regenestem.com) is a U.S.-based medical practice company focused on providing comprehensive solutions involving adult stem cell treatments and research. The firm has assembled a talented staff of medical specialists - professionals trained in the latest cutting-edge procedures and protocols in cellular medicine. Regenestem is certified for the medical tourism market - and staff physicians are board-certified or board-eligible, providing services in more than 10 specialties. Regenestem investigates, shares, utilizes and integrates the latest protocols in the adult stem cell arena to deliver the best medical solutions to its patients. The brand includes a membership association of regenerative medicine clinics, a training and education division, and an online store.
Ricardo De Cubas, Regenestem, http://www.regenestem.com, +1 (305) 224-1858, [email protected]
Share this article